Literature DB >> 6991427

Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosis.

E C Hayes, S D Gollobin, C E Machamer, L K Westfall, H J Zweerink.   

Abstract

Immunoprecipitation methods were used to analyze sera and cerebrospinal fluids from patients with multiple sclerosis for measles virus-specific antibodies. The sera contained antibodies against all virus antigens except the matrix polypeptide. Of the nine cerebrospinal fluids investigated, two contained undetectable levels of measles-specific antibodies, four contained antibodies against the nucleocapsid and another internal antigen, and three contained antibodies against the surface antigens as well as the internal antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991427      PMCID: PMC550876          DOI: 10.1128/iai.27.3.1033-1037.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A comparison of the polypeptides of four measles virus strains.

Authors:  W E Mountcastle; P W Choppin
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

3.  Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum.

Authors:  E Norrby; H Link; J E Olsson
Journal:  Arch Neurol       Date:  1974-04

4.  Intracellular synthesis of measles virus-specified polypeptides.

Authors:  S L Wechsler; B N Fields
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

5.  Glycoproteins of measles virus under reducing and nonreducing conditions.

Authors:  J M Hardwick; R H Bussell
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

6.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Staphylococcal protein A-sepharose columns and the characterization of measles virus-specific polypeptides in persistently infected cells.

Authors:  E C Hayes; L L Wright; H J Zweerink
Journal:  Anal Biochem       Date:  1978-11       Impact factor: 3.365

8.  Antibodies against the measles matrix polypeptide after clinical infection and vaccination.

Authors:  C E Machamer; E C Hayes; S D Gollobin; L K Westfall; H J Zweerink
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

  8 in total
  10 in total

1.  Elevated antibody levels against measles virus P protein in sera of patients with multiple sclerosis.

Authors:  S L Wechsler; H C Meissner
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

2.  Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.

Authors:  R W Hankins; F L Black
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Identification of immunogenic outer membrane proteins of Pasteurella multocida 3:A in rabbits.

Authors:  Y S Lu; S J Afendis; S P Pakes
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

4.  Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system.

Authors:  E J Hansen; C F Frisch; R L McDade; K H Johnston
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections.

Authors:  M Graves; D E Griffin; R T Johnson; R L Hirsch; I L de Soriano; S Roedenbeck; A Vaisberg
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Antibodies against measles virus polypeptides in different disease conditions.

Authors:  E Norrby; C Orvell; B Vandvik; J D Cherry
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  A monoclonal antibody against a Pasteurella multocida outer membrane protein protects rabbits and mice against pasteurellosis.

Authors:  Y S Lu; W C Lai; S P Pakes; L C Nie
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Antibody response to individual rubella virus proteins in congenital and other rubella virus infections.

Authors:  S Katow; A Sugiura
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

9.  Hyperimmune serum from rabbits immunized with potassium thiocyanate extract of Pasteurella multocida protects against homologous challenge.

Authors:  Y S Lu; S P Pakes; L Massey
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  Pathogenesis and immune response of vaccinated and unvaccinated rhesus monkeys to tick-borne encephalitis virus.

Authors:  P Hambleton; J R Stephenson; A Baskerville; C N Wiblin
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.